March 31, 2020 07:21 AM EDTUpdated April 1, 04:19 AM
Coronavirus

Covid-19 roundup: GSK, Am­gen tai­lor R&D work to fit the coro­n­avirus age; Doud­na's ge­nomics crew launch­es di­ag­nos­tic lab

ENDPOINTS

You can add Am­gen and GSK to the list of deep-pock­et drug R&D play­ers who are tai­lor­ing their pipeline work to fit a new age …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis ups in­come guid­ance, ini­ti­ates $10B share buy­back

Sarep­ta adds black box warn­ing to its Duchenne treat­ment, cuts 500 work­ers

OpenEv­i­dence raised $210M in GV's 'most com­pet­i­tive' deal

Jeanne Mar­raz­zo, NI­AID di­rec­tor placed on leave, on 'biggest threat­s' to HIV med­i­cine

RFK reshuf­fles top HHS lead­er­ship, re­plac­ing his chief of staff and an­oth­er top aide

Wear­able mak­er Whoop to fight FDA over blood pres­sure track­er

A service from the Financial Times